NetworkNewsBreaks – Nano-X Imaging Ltd. (NASDAQ: NNOX) Strengthens UK Market Access and Hospital-Based AI Capabilities
Nano-X Imaging Ltd. (NASDAQ: NNOX) (“Nanox”), an innovative technology company, is advancing Nanox.AI’s commercial and technology strategy through two developments aimed at expanding the use of AI in medical imaging. An exclusive three-year reseller agreement with Vertec Scientific, including minimum annual license commitments, establishes a dedicated UK channel for HealthOST, an AI-powered software solution that delivers qualitative and quantitative analysis of spinal CT images to help clinicians evaluate and assess spinal musculoskeletal disease, including osteoporosis. Separately, Nanox.AI has optimized its imaging AI framework for Intel Core Ultra processors using OpenVINO, demonstrating the potential to run AI inference locally on hospital hardware and reduce reliance on cloud connectivity. Together, these developments support Nanox.AI’s strategy of extracting additional clinical value from already performed scans while expanding commercial reach and offering healthcare providers more flexible deployment options.
To view the full article, visit https://nnw.fm/xnQJg
NOTE TO INVESTORS: The latest news and updates relating to NNOX are available in the company’s newsroom at https://nnw.fm/NNOX
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
Nano-X Imaging Ltd. (NASDAQ: NNOX) (“Nanox”), an innovative technology company, is advancing Nanox.AI’s commercial and technology strategy through two developments aimed at expanding the use of AI in medical imaging. An exclusive three-year reseller agreement with Vertec Scientific, including minimum annual license commitments, establishes a dedicated UK channel for HealthOST, an AI-powered software solution that delivers qualitative and quantitative analysis of spinal CT images to help clinicians evaluate and assess spinal musculoskeletal disease, including osteoporosis. Separately, Nanox.AI has optimized its imaging AI framework for Intel Core Ultra processors using OpenVINO, demonstrating the potential to run AI inference locally on hospital hardware and reduce reliance on cloud connectivity. Together, these developments support Nanox.AI’s strategy of extracting additional clinical value from already performed scans while expanding commercial reach and offering healthcare providers more flexible deployment options.
To view the full article, visit https://nnw.fm/xnQJg
NOTE TO INVESTORS: The latest news and updates relating to NNOX are available in the company’s newsroom at https://nnw.fm/NNOX
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
